Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant
Nature Communications, ISSN: 2041-1723, Vol: 9, Issue: 1, Page: 3695
2018
- 48Citations
- 171Usage
- 77Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations48
- Citation Indexes48
- 48
- CrossRef25
- Usage171
- Downloads130
- Abstract Views41
- Captures77
- Readers77
- 77
- Mentions1
- Blog Mentions1
- 1
Most Recent Blog
Nature Communications - 12 September 2018
Advertisement Asia Pacific Vascular Biology Organization Conference, May 9-12, 2019, Guangzhou, China. Register Now. More than thirty-four international renowned top speakers. Zhongshan Ophthalmic Center (ZOC),
Article Description
Protein/subunit vaccines often require external adjuvants to induce protective immunity. Due to the safety concern of chemical adjuvants, physical adjuvants were recently explored to boost vaccination. Physical adjuvants use physical energies rather than chemicals to stimulate tissue stress and endogenous danger signal release to boost vaccination. Here we present the safety and potency of non-invasive radiofrequency treatment to boost intradermal vaccination in murine models. We show non-invasive radiofrequency can increase protein antigen-induced humoral and cellular immune responses with adjuvant effects comparable to widely used chemical adjuvants. Radiofrequency adjuvant can also safely boost pandemic 2009 H1N1 influenza vaccination with adjuvant effects comparable to MF59-like AddaVax adjuvant. We find radiofrequency adjuvant induces heat shock protein 70 (HSP70) release and activates MyD88 to mediate the adjuvant effects. Physical radiofrequency can potentially be a safe and potent adjuvant to augment protein/subunit vaccine-induced humoral and cellular immune responses.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85053265705&origin=inward; http://dx.doi.org/10.1038/s41467-018-06151-y; http://www.ncbi.nlm.nih.gov/pubmed/30209303; https://www.nature.com/articles/s41467-018-06151-y; https://digitalcommons.uri.edu/bps_facpubs/62; https://digitalcommons.uri.edu/cgi/viewcontent.cgi?article=1066&context=bps_facpubs; https://dx.doi.org/10.1038/s41467-018-06151-y
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know